Navigation Links
Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results
Date:11/7/2007

SEATTLE, Nov. 8 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) today reported recent accomplishments and financial results for the quarter and nine months ended September 30, 2007.

Recent Events

-- Announced agreement to acquire ZEVALIN(R) (ibritumomab tiuxetan), the

first FDA-approved radioimmunotherapy, from Biogen Idec; this

acquisition, if completed, will return CTI to a select group of only a

few biotech companies which market and sell a commercial product

-- Announced a potential abbreviated registration path for pixantrone

based on the Company's decision to do a full analysis of the EXTEND

(PIX301) phase III clinical trial for patients with relapsed,

aggressive non-Hodgkin's lymphoma (NHL), which is targeted for data

release in mid-2008

-- Added brostallicin, a novel phase II cancer drug candidate to CTI's

portfolio through its acquisition of Systems Medicine Inc., a privately

held company connected with the Translational Genomics Research

Institute

-- Added Richard L. Love, former founder and CEO of Triton Biosciences

Inc. and ILEX Oncology, Inc. to its board of directors

-- Received special protocol assessment (SPA) approval of and launched a

phase III clinical trial, known as PIX303, of pixantrone for patients

with indolent NHL who have relapsed following first-line therapy

-- Received SPA approval of and launched a confirmatory phase III clinical

trial, known as PGT307, of XYOTAX(TM) (paclitaxel poliglumex, CT-2103)

in combination with carboplatin for women with pre-menopausal estrogen

levels who have advanced non-small cell lung cancer (NSCLC)

"Our acquisition of Systems Medicine, Inc. and our proposed acquisition of ZEVALIN, coupled with progress on advancing XYOTAX toward a first half 2008 marketing application submission a
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
2. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
3. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
4. Cell Therapeutics, Inc. (CTI) CIBC and Rodman & Renshaw Healthcare Conference Presentations to be Webcast
5. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 8
6. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
7. Haemacure Reports Third Quarter 2007 Results
8. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. MDS Reports Third Quarter 2007 Results
11. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... of the antidepressant Lexapro appears to help prevent ... study finds. The condition is known ... people with this condition may not develop noticeable ... blood supply, according to researchers from Duke University ... the researchers found that people taking the antidepressant ...
(Date:5/22/2013)... By Dennis Thompson HealthDay Reporter , , TUESDAY, ... Americans isn,t improving much, with about six in 10 ... in unhealthy behaviors like smoking, heavy drinking or not ... Tuesday by the U.S. Centers for Disease Control and ... of the lifestyle choices that have led to soaring ...
(Date:5/22/2013)... May 22 (HealthDay News) -- Roughly four in 10 ... pulmonary disease (COPD) actually do not have the lung ... Faulty diagnoses were made based on an evaluation of ... standard" disease test known as spirometry, which shows how ... amount of air they can exhale and how long ...
(Date:5/22/2013)... Atlanta, GA (PRWEB) May 22, 2013 ... marketing agency, JD Media Surge, LLC, E-Dentists.com has ... subjects. The blog will feature numerous topics of ... on treatment options and dental health. , ... element of dental Internet marketing. In addition to ...
(Date:5/22/2013)... Macedon, NY (PRWEB) May 22, 2013 ... other lean manufacturing improvements use the new Do-Done StepTracker ... coordination. “We use the Do-Done board to display the ... Each of our production cells and departments is listed ... top. As we start a project, the squares are ...
Breaking Medicine News(10 mins):Health News:Antidepressants May Be Helpful for Some Heart Patients: Study 2Health News:Antidepressants May Be Helpful for Some Heart Patients: Study 3Health News:Americans Still Making Unhealthy Choices: CDC 2Health News:Americans Still Making Unhealthy Choices: CDC 3Health News:COPD May Be Over-Diagnosed Among Uninsured 2Health News:Dental SEO Blog Launched by E-Dentists.com in Partnership with JD Media Surge, LLC 2Health News:Project Managers Organize Manufacturing Projects and Training with the New Steptracker Project Status Magnetic Whiteboards 2
... N.J., July 9 Red wine (resveratrol) pills appear to be ... to lead the way for patients and consumers to learn more ... do so. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090709/LA44390 ) , ... of red wine pills, a local cardiology group says it will ...
... Today Americans United for Life (AUL) President & CEO Dr. ... members, urging them to ask Judge Sotomayor the "Top Ten" most ... the Court as the Senators prepare for her confirmation hearings to ... CEO Dr. Charmaine Yoest said, "It,s important for the American people ...
... As part of its Patient Voices series, ... is featuring the stories of people from across the country who ... Patient Voices seeks to give a glimpse into the life ... diverse as the disease itself, and include actress/model and Lupus Foundation ...
... 1 diabetes or having a preceding infection are associated with more ... 49 years old, according to a Finnish study. Furthermore, heart failure ... cancer malignancy with 16 times the risk of death in stroke ... group, said Jukka Putaala, M.D., who led the study. Risk of ...
... The President of the American Chemical Society, ... President Obama,s nomination of Francis Collins, M.D., Ph.D., to ... other time in recent memory has there been such a ... of science to deliver solutions to the grand challenges facing ...
... hits $42 million a year , THURSDAY, July 9 (HealthDay News) ... at least $42 million a year, a new study finds. , ... 100,000 young people annually, said Dr. Warren Lo, lead author of ... but there is growing concern about the cost of medical care ...
Cached Medicine News:Health News:Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine (Resveratrol) Pills, Issue Consumer Precautions 2Health News:Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine (Resveratrol) Pills, Issue Consumer Precautions 3Health News:Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine (Resveratrol) Pills, Issue Consumer Precautions 4Health News:AUL President to Senate Judiciary Committee: Ask Top 10 Questions to Judge Sotomayor 2Health News:The New York Times Website Patient Voices Series Features People Affected by Lupus 2Health News:Stroke in Children Rare But Costly 2Health News:Stroke in Children Rare But Costly 3
(Date:5/22/2013)... 22, 2013 MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) ... about some recent company developments. As Medifirst continues to ... communication with shareholders. Integrating social media into its investor ... and will post updates on Twitter.  The Facebook homepage ... Says CEO Bruce J. ...
(Date:5/22/2013)... --  Life Line Screening  (LLS), a leading national ... of a unique partnership with MCM Solutions for ... a population health management organization. LLS will provide health ... important expanded services will help MCM and its clients ... cost of care when individuals are able to address ...
(Date:5/22/2013)... , May 22, 2013  Generex Biotechnology Corporation ... demonstrating the superiority of the AE37 breast cancer vaccine ... ( www.antigenexpress.com ). The presentations will be made at ... Oncology (ASCO) to be held in Chicago ... The presentation entitled " Booster inoculations of ...
Breaking Medicine Technology:Medifirst Solutions, Inc. Announces Update To Shareholders 2Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: